Patents by Inventor Daniela Lecca

Daniela Lecca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTION
    Publication number: 20260055061
    Abstract: Halophthalimides are disclosed. The halophthalimides may inhibit TNF-? activity, TNF-? synthesis, inflammation, inducible nitric oxide synthase, SARS-CoV-2 virus, or any combination thereof. The halophthalimides may be administered to a subject with a traumatic brain injury, an inflammatory disorder, an autoimmune disorder, a neurodegenerative disease, a viral infection, or any combination thereof. The disclosed halophthalimides have a structure according to Formula I, or a stereoisomer or pharmaceutically acceptable salt, solvate, or hydrate thereof, where R5 is At least one of R2-R4 or Re is halo.
    Type: Application
    Filed: August 7, 2023
    Publication date: February 26, 2026
    Applicants: The United States of America, as represented by the Secretary, Department of Health & Human Services, AevisBio, Inc.
    Inventors: Nigel H. Greig, Weiming Luo, David Tweedie, Michael T. Scerba, Daniela Lecca, Shih Chang Hsueh, Dong Seok Kim